"Follow-On Biologics": Ensuring Continued Innovation in the Biotechnology Industry

"Follow-On Biologics": Ensuring Continued Innovation in the Biotechnology Industry

Publication

An article co-authored by Bruce Manheim, published by Health Affairs (Vol. 25, No. 2, 2006), discusses new protein products that will likely need more market protection than what is provided to new drug products. Read the full article

Authors

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.